Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 24, 2010
Clinical impact and cost of monitoring for asymptomatic laboratory abnormalities among patients receiving antiretroviral therapy in a resource-poor settingSerena P Koenig, Bruce R Schackman, Cynthia Riviere, et al.The American Journal of Tropical Medicine and Hygiene|June 3, 2011
AIDS diarrhea and antiretroviral drug concentrations: a matched-pair cohort study in Port au Prince, HaitiRebecca Dillingham, Paul Leger, Carole-Anne Beauharnais, et al.Immunotherapy|July 3, 2026
Anti-PD-(L)1 plus chemotherapy in advanced PD-L1-negative nonsquamous non-small cell lung cancer: a systematic review and meta-analysisNicolas Peruzzo, Gabriel Lenz, Rafael Alvim Pereira, et al.Frontiers in Oncology|August 27, 2024
The impact of neoadjuvant relugolix on multi-dimensional patient-reported fatigueJessica Y Hsueh, Lindsey Gallagher, Min Ji Koh, et al.Frontiers in Oncology|February 3, 2025
Maintenance of patient-reported health-related quality of life post neoadjuvant relugolix prior to the initiation of prostate radiation therapyMin Jung Koh, Min Ji Koh, Jessica Y Hsueh, et al.The New England Journal of Medicine|December 2, 2005
Antiretroviral therapy in a thousand patients with AIDS in HaitiPatrice Severe, Paul Leger, Macarthur Charles, et al.Frontiers in Oncology|November 2, 2023
Early biochemical outcomes following neoadjuvant/adjuvant relugolix with stereotactic body radiation therapy for intermediate to high risk prostate cancerLindsey Gallagher, Jerry Xiao, Jessica Hsueh, et al.Frontiers in Oncology|February 14, 2025
Utilization of patient-reported outcomes to assess adherence to relugolix when combined with stereotactic body radiation therapy for intermediate to high-risk prostate cancerKelly Gaudian, Min Jung Koh, Min Ji Koh, et al.Frontiers in Oncology|April 26, 2024
Impact of neoadjuvant relugolix on patient-reported sexual function and botherJessica Y Hsueh, Lindsey Gallagher, Min Ji Koh, et al.Bulletin of the World Health Organization|January 15, 2009
Survival, plasma HIV-1 RNA concentrations and drug resistance in HIV-1-infected Haitian adolescents and young adults on antiretroviralsMacarthur Charles, Francine Noel, Paul Leger, et al.Pageof 3